Summary
- Current Price
- As of today, TXG price is $46.56, down -1.04% in the most recent trading session on
- Current Price All-Time High
- TXG price is currently -77.72% below its historical high of $208.99 set on
- Market Cap
- TXG current market cap is $6B, up +239.29% over the past 365 days
- Revenue
- TXG current annual revenue is $642.82M, up +5.25% year-over-year
- Next Earnings
- The next earnings release for TXG is on
Profile
| Metric | Value |
|---|---|
| Full Name | 10x Genomics, Inc. |
| Ticker | NASDAQ: TXG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 10xgenomics.com |
| Employees | 1,306 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $46.56 | |
| Price, 1D Change | -1.04% | |
| $6B | ||
| - | ||
| - | ||
| 2.33 | ||
| $643M | ||
| Revenue, 1Y Change | +5.25% | |
| -$0.35 | ||
| EPS, 1Y Change | +76.98% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | N/A | $0.00 |
| EPS Est. Change | N/A | +100.00% |
| $642.82M | ||
| Revenue Estimate | N/A | $614.06M |
| Revenue Est. Change | N/A | -4.47% |
| Current Price | $46.56 | |
| Price Target | - | $40.00 |
| Price Tgt. Change | - | -14.09% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.61 | -$1.52 | -147.22% | |
| -$0.03 | -$0.35 | -1,207.49% | |
| $0.00 | N/A | +100.00% | |
| $0.21 | N/A | +159.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $610.74M | $610.79M | +0.01% | |
| $640.23M | $642.82M | +0.41% | |
| $614.06M | N/A | -4.47% | |
| $671.47M | N/A | +4.46% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $46.56 | |
| $22.47 | ||
| $34.01 | ||
| $24.96 | ||
| $35.96 | ||
| $3.74 | ||
| 2.33 | ||
| $2.75 | ||
| 64.70 | ||
| 77.06% | ||
| 70.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $642.82M | ||
| -$0.35 | ||
| $443.88M | ||
| 69.05% | ||
| -$110.89M | ||
| -17.25% | ||
| -$43.54M | ||
| -6.77% | ||
| -$56.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.11 | ||
| 4.46 | ||
| 4.09 | ||
| - | ||
| 5 | ||
| 13.32 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 9.25 | ||
| 7.26 | ||
| -177.18 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $796.33M | ||
| $523.41M | ||
| $1.04B | ||
| $684.45M | ||
| $245.04M | ||
| $153.45M | ||
| $84.36M | ||
| $10.99M | ||
| $12.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $686.37M | ||
| $554.77M | ||
| $198.94M | ||
| $0.00 | ||
| $43.82M | ||
| $0.00 | ||
| $3.64M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $136.05M | ||
| -$13.44M | ||
| $6.80M | ||
| $5.94M | ||
| $130.12M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Canaccord Genuity | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with TXG
FAQ
What is the ticker symbol for 10x Genomics, Inc.?
The ticker symbol for 10x Genomics, Inc. is NASDAQ:TXG
Does 10x Genomics, Inc. pay dividends?
No, 10x Genomics, Inc. does not pay dividends
What sector is 10x Genomics, Inc. in?
10x Genomics, Inc. is in the Healthcare sector
What industry is 10x Genomics, Inc. in?
10x Genomics, Inc. is in the Health Information Services industry
What country is 10x Genomics, Inc. based in?
10x Genomics, Inc. is headquartered in United States
When did 10x Genomics, Inc. go public?
10x Genomics, Inc. initial public offering (IPO) was on September 12, 2019
Is 10x Genomics, Inc. in the S&P 500?
No, 10x Genomics, Inc. is not included in the S&P 500 index
Is 10x Genomics, Inc. in the NASDAQ 100?
No, 10x Genomics, Inc. is not included in the NASDAQ 100 index
Is 10x Genomics, Inc. in the Dow Jones?
No, 10x Genomics, Inc. is not included in the Dow Jones index
When was 10x Genomics, Inc. last earnings report?
10x Genomics, Inc.'s most recent earnings report was on May 7, 2026
When does 10x Genomics, Inc. report earnings?
The next expected earnings date for 10x Genomics, Inc. is August 6, 2026
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000162828026007822/0001628280-26-007822-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg